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1. Introduction 
Anxiety and depression are predisposing psychosocial risk factors for 
cardiovascular disease (CVD) (1). The relationship between these risk factors 
and CVD is not unilateral, but rather complex and reciprocal in nature. It is a 
peculiar phenomenon that the negative effects of this comorbidity expand to both 
psychological and physical dimensions, reciprocally. According to several 
reviews (2, 3) and a recent meta-analysis (4), the presence of depression and/or 
anxiety disorders is linked with increased incidence of recurrent cardiac events, 
sudden death and poorer prognoses in individuals with CVD. Within the context 
of CVD, physical ailments inhibit functioning which can lead to anxiety and 
depression, which can in turn lead to the worsening of CVD (2). Furthermore, 
such symptoms are generally uncorrelated with disease indices, highlighting their 
importance as an issue to be considered in addition to the physical ailment (5). 
Anxiety and depression are more predictive of functional impairment in 
individuals with medical conditions, such as CVD, than the severity of the 
physical ailment itself: the severity of the anxiety/depression is indicative of the 
severity of the risk to the individual (2). 
 Based on the assertion that anxiety and depression are predisposing risk 
factors for CVD and that inextricably links between these disorders exist, the 
ability of the Hospital Anxiety and Depression Scale (HADS) (6) to capture these 
phenomena should be subject to scrutiny. While a phenomenological 
assessment of anxiety and depression provides distinct disparities, an empirical 
divide between these closely related disorders has been elusive (7). The degree 
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of overlap between symptoms of anxiety and depression across HADS items is 
marked, calling into question the ability of the scale to differentiate between these 
disorders. While the disparate subscales of the HADS are intended to measure 
mutually exclusive levels of anxiety (HADS-A) and depression (HADS-D) a 
recent systematic review of the latent structure of the HADS does not support the 
traditional anxiety-depression bidimensional structure (8). Furthermore, a 
systematic review of the case-finding ability of the HADS indicates that the HADS 
is a useful tool in the identification of non-psychiatric patients with emotional 
distress; however, concern for the ability to distinguish between emotional 
disorders is also voiced (9).  For clinicians, cognizance of the structure of the 
HADS can enhance the ability to swiftly assess symptom severity, given the 
inherent hierarchical structure of psychiatric morbidity, (10).The marked overlap 
between symptoms of anxiety and depression in the context of the HADS items 
highlights the need for further investigation into the ability of the HADS to 
accurately differentiate between anxiety and depression.  
Previous studies with individuals with CVD have provided mixed evidence 
as to the latent structure of the HADS, revealing one- (11), two- (12, 13), and 
three-factor models (14-21). If a two-factor latent variable structure of the HADS 
cannot be confirmed, it cannot be conclusively deduced that the HADS is 
accurately measuring, and differentiating between, anxiety and depression (22). 
While the majority of studies have supported a three-factor structure of the 
HADS, the single-scale model of the HADS has received nearly unanimous 
support amongst extant studies using item response theory (IRT) methods (23-
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25). Although nearly all of the studies supporting the three-factor model have 
employed classical test theory (CTT) methods, a recent IRT study employing 
Mokken scaling also found a three-factor structure (19). 
Despite the popularity of CTT methods, such as factor analysis, IRT has 
significant advantages over CTT, potentially providing much more compelling 
evidence of the latent structure of the HADS (26). Results derived from CTT 
methods are confined to the population in which the original study was 
conducted; however, through the incorporation of item information into the ability-
estimation process and conversely the incorporation of examinee ability into 
item-parameter estimation, IRT results can be applied beyond the scope of the 
original study (27). Given the limitations of CTT methods and the robust evidence 
provided by IRT, further investigation using IRT methods is warranted. A 
potential drawback of many IRT methods are difficulties in fitting an appropriate 
model to the data, these shortcomings are most pronounced in parametric IRT 
methods, e.g. Rasch analysis. Therefore, a non-parametric IRT method, Mokken 
scaling, is used in the current study.  
2. Methods 
A secondary analysis of cross-sectional HADS data collected from four 
independent studies of CVD in Ireland was conducted. These HADS data were 
aggregated into a single dataset and analysis of the latent variable structure of 
the HADS was conducted via Mokken scaling.  
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2.1. Participants  
Four studies including individuals with heart failure, acute coronary syndrome, 
and post-coronary artery bypass graft surgery were included in the data 
conglomerate: the Coronary Care Unit (CCU) study, the Heart Failure (HF) study, 
the Psychological Well-Being (PWB) study, and the Coronary Artery Bypass 
Graft (CABG) study(28, 29). HADS data from 893 participants was collected from 
the contributing studies (CCU, n=444; HF, n=90; PWB, n=85; CABG, n=274); 
these data were collected via different methods, within different diagnostic 
populations and at different times (further details of the study methods are 
available from the corresponding author).  
2.2. Materials 
Zigmond & Snaith’s (1983) HADS is a 14-item self-assessment scale used 
to detect possible (>8) and probable (>11) depression and anxiety disorder cases 
in non-psychiatric hospital outpatients.  The HADS is composed of two seven-
item subscales, the HADS-A and HADS-D measuring anxiety and depression, 
respectively.   
2.3. Data Analysis  
Missing data (comprising less than 1% of the total data points) were 
imputed via a regression based impute function in STATA, calculating missing 
items based on completed scale items. After imputation the data were rounded to 
the nearest number, as the HADS deals exclusively with whole numbers.  
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Data were analyzed using PASW 18.0 (30), with Mokken analysis 
conducted in STATA 9.2 (31) and R 2.11.1 (32). MSP was conducted with the 
“msp” function in STATA, written by Jean-Benoit Hardouin (33). The scale 
extracted from MSP was examined for monotone homogeneity and invariant item 
ordering using R. 
Mokken Scaling Procedure (MSP), a nonparametric IRT model, is a 
probabilistic version of Guttman scale analysis used to assess the dimensionality 
and scalability of psychometric measures (34, 35). Guttman scaling involves a 
set of increasingly “extreme” binary items to which an examinee responds, under 
the assumption that an examinee responding positively to a more extreme item 
will respond positively to a less extreme item. MSP posits a stochastic 
relationship between the item and underlying variables, improving upon the 
deterministic nature, and the uninformative step shaped item characteristic curve, 
associated with Guttman scaling (36).  
Unidimensional scales are formed in MSP using a “bottom up” hierarchical 
clustering procedure (34).  Using the homogeneity coefficient (Hij) as the 
clustering criterion, the pair of items with the highest Hij is selected (34). After the 
first pair of items has been extracted, the item with the next best fit in the scale is 
selected (34). Inclusion of items onto a respective scale proceeds based on the 
fulfillment of the criterion of positive covariation with the previous item, a 
Loevinger H-value (H) above the coefficient value (c) and of the item increasing 
the overall H value of the previously selected items. This procedure is repeated 
until no remaining items meet inclusion criteria for that scale (37).  Once a scale 
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has been saturated with items meeting its inclusion criteria, a new scale is 
formed and the process continues until all of the items have been used or 
specifically excluded due to failure to fulfill inclusion criteria. For each user-
defined coefficient level a potentially unique set of scales can be created; the 
most interpretable scales are then extracted from a given c level (36, 38).  Due to 
minimal model assumptions in relation to parametric IRT models, a larger 
number of items can be included in the creation of a scale, which has lead some 
researchers to describe MSP as “exempli[fying] the purest form of 
unidimensionality” (39) . According to Meijer & Baneke (2004) the minimum 
sample size for MSP is 400. 
The ability of a scale to discriminate via its component items and 
subsequently differentiate and order examinees is determined by the scale’s H 
value (36). The H value for a scale is calculated using the formula: H = 1 – 
(Observed Guttman Error/Predicted Guttman Errors).  Predicted Guttman errors 
are based on the probability that an item will be chosen by chance, given the 
item difficulty, whereas observed Guttman errors are responses that are “out of 
order” in the Guttman sequence (36).  Higher H values are obtained when fewer 
observed Guttman errors occur, in other words, when a greater number of items 
are responded to in a manner that corresponds with the proper sequence. For 
the purposes of interpretation 0.3≥H≥0.4 indicates a weak scale, 0.4≥H≥0.5 
indicates a moderate scale, and H≥0.5 indicates a strong scale (36).    
Increasing user defined coefficient values (c) were entered, according to 
Meijer & Baneke’s (36) MSP procedure. After an initial screen at .01, c values 
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were incrementally increased by .05 from .05 to .6, inclusive, using c as the 
lower-bound cutoff score for scale inclusion. Output from the various c 
increments were evaluated in terms of interpretability, extracting the most 
interpretable solution (36). Scales extracted at higher c values, with 
correspondingly high H-values, and those including a greater number of items 
were deemed more interpretable. Of these potential scales, the scales that 
included the most items that could be intuitively grouped, i.e. according to similar 
symptoms or disorders, were extracted. These extracted scales were then 
examined for violations of the assumption of monotone homogeneity as well as 
for invariant item ordering. Invariant item ordering, i.e. the same ordering of item 
difficulty across varying levels of the latent variable, is often considered 
desirable, but not integral, to the interpretability of scale results (40). 
3. Results 
Demographics and details of disease indices are shown in Table 1. All of 
the respondents had at least one form of cardiovascular disease, 90 had 
experienced heart failure, 274 underwent coronary artery bypass surgery, and 
529 had acute coronary syndrome.  Further details of the specific study 
demographics are available from the corresponding author. 
 
Insert Table 1 here 
 
Mokken Scaling Procedure 
 The results of the Mokken analyses are shown in Table 2.  
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Insert Table 2 here 
 
At c=.30 a moderate unidimensional scale (H= .41) including 12 of 14 
HADS items was created. At c=.40 one moderate (H= .49) and one strong (H= 
.60) scale were formed with items 1, 3, 5, 6, 7, 9, 10, 11, 13 and 2, 4, 12, 
respectively. At c=.50 three strong scales were formed: items 1, 3, 5, 6, 13 
(H=.60); items 2, 4, 12 (H= .60); items 7, 9 (H= .51). 
Visual inspection of the 12 item scale extracted at c=.30 showed no 
violations of monotone homogeneity. Analysis of invariant item ordering revealed 
six items with no violations (items 4, 7, 8, 10, 11, 12; HT=.32).  
4. Discussion 
 The HADS has been extensively used under the assumption that it 
captures two dimensions (anxiety and depression); however, the current study 
reveals that the HADS captures a single overarching dimension: general 
psychological distress.  The inclusion of 12 of the 14 HADS items compounded 
by the strength of the scale made the general psychological distress scale the 
most interpretable of the extracted models.  
 Several alternative models were revealed at the c=.40 and .50 levels; 
however, the low levels of interpretability did not provide robust evidence of the 
existence of the proposed two- and three-dimensional models. At c=.4, the 
scales provide neither evidence for the original anxiety-depression model nor a 
clear depiction of uniformly captured symptoms. Scale 2 (“Anhedonia”) is 
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composed solely of anhedonic depression items, a dimension that has received 
support in previous models (41); however, anhedonic depression items 6 and 10 
are also present on scale 1 (“General Distress”). Both the General Distress scale 
and the Anhedonia scale contain anhedonia items, in contrast to all of the prolific 
models of depression and anxiety, i.e. Caci (42), Dunbar (41), Friedman (43), 
Moorey (44), Razavi (45) and Zigmond (6), that do not split the depression items.  
The c=.50 model reveals a three-dimensional structure combining four 
anxiety items and one depression onto a scale (“General Distress”), eliminating 
three depression items and forming a scale with the remaining depression items 
(“Anhedonia”) whilst creating a third, two anxiety item, scale (“Anxiety”). This 
three-dimensional model bears no resemblance to any of the established three-
dimensional structures (41-43) or tripartite theories of depression and anxiety 
(46). Furthermore, this model also excludes four items, three of four items 
deemed by Zigmond & Snaith’s (1983) to be “mandatory”; therefore, providing 
insufficient evidence of the interpretability of this model.  
The single-scale model provides a statistically viable, clinically useful 
measure of general psychological distress.  Similar to the two- and three-scale 
models, the one-scale model could not differentiate between anxiety and 
depression; however, the inclusion of all but items 8 (“I feel as if I am slowed 
down”) arguably the only somatic/fatigue item, and 14 (“I can enjoy a good book 
or radio or TV program”), indicates that the scale is capturing something broader 
than the specific disorders of anxiety and depression. While invariant item 
ordering is a desirable attribute of a scale, it is not necessary (40); therefore, 
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failure to create an interpretable item invariant scale, due to the exclusion of 
more than half (8) of the 14 HADS items, does not impede the viability of the 
general psychological distress scale. 
Although two items are not included in the scale, neither of these items 
were included amongst the eight items deemed “mandatory” by Zigmond & 
Snaith during the creation of the HADS (6). Given the average age of the 
respondents, item 8 (“I feel as if I am slowed down”) may have captured, and 
subsequently been confounded with, the benign slowing of activities associated 
with ageing. It is plausible that “slowed down” may have been misinterpreted as a 
generalized slowing rather than the intended depressive symptom of fatigue; 
capturing not only mood, but manifestations of somatic illness and/or cognitive 
slowing (11, 47). Item 14 could be criticized as having lost its cultural relevance 
and ability to assess anhedonia as it is intended to and has been shown to have 
poor discriminative abilities (28, 48). The validity of this item has been questioned 
in acute medical wards (11), suggesting that these activities may never be 
enjoyed in the hospital environment in which the HADS is completed. Despite 
eliminating two HADS items, the one scale model maintains its psychometric 
viability based on the questionable validity of the eliminated items.  
While the symptomatic overlap demonstrated by the HADS is seen as a 
flaw in the bidimensional model, it provides strong evidence for the 
unidimensional general psychological distress model. In the general 
psychological distress model the intent is to capture and quantify symptoms of 
both anxiety and depression; therefore, whether or not a particular item captures 
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just one of the two disorders is irrelevant. In individuals with CVD, the clinical 
relevance of the general psychological distress model rests in the inextricable 
links between anxiety and depression in the course of the disease. 
As outlined previously, anxiety and depression are both prognostic risk 
factors for CVD, highlighting the need to be able to assess these disorders via 
the HADS (49-55). Having the ability to quantify mutually exclusive levels of 
anxiety and depression is an integral component of assessment when the 
prognoses are specifically predicted by one or the other disorder; however, in the 
case of CVD, both anxiety and depression are prognostic risk factors, negating 
the need to differentiate between these disorders. Consequently, using the 
HADS as a unidimensional measure of general psychological distress will not 
impede its ability to provide timely and invaluable information to clinicians 
regarding the prognoses of individuals with CVD.  
The unidimensional general psychological distress model of the HADS 
should be adopted by both clinicians and researchers alike.  Given the degree of 
controversy that has arisen with regards to the structure of the HADS, in this 
case, simplicity may be the best policy. Rather than concerning themselves with 
categorically dividing symptoms with increasing levels of precision, adopting a 
more holistic viewpoint will enable clinicians to be able to be more cognizant of 
the overall psychological status of the individuals, avoiding a “missing the forest 
for the trees”-type situation. While a need may exist for other somatic disorders 
to be able to accurately differentiate between anxiety and depression, the current 
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study demonstrates that in the case of prognostic risk factors in CVD, the general 
psychological distress model of the HADS is an appropriate psychometric fit. 
A limitation of the current study is the potential for a small number of 
participants to have been included across the samples. While this is highly 
unlikely, given that the samples were recruited over a 7-year timeframe, and 
across disparate locations, eliminating this possibility is not possible, due to the 
subsequent anonymization of the data and the passage of time since these data 
were collected. 
 The results from the current study provide strong evidence of the 
existence of a unidimensional model of general psychological distress in the 
HADS.  The two-scale and three-scale models exhibited cross-loading of anxiety 
and depression items and confounding of symptoms across scales, resulting in 
the rejection of these models and provision of additional support for the ability of 
the unidimensional general psychological distress model to accurately capture 
symptoms of both anxiety and depression. The single latent variable model of 
general psychological distress found in the current study was both statistically 
viable and included 12 of the 14 HADS items, providing further evidence of its 
ability to capture symptoms of anxiety and depression.  
 The HADS has been used prolifically under the assumption of a 
bidimensional structure of anxiety-depression; however, the current study reveals 
that the underlying variable structure of the HADS is unidimensional. Being able 
to provide more compelling evidence of the structure of any psychometric tool 
should be a top priority for researchers; therefore, employing statistical methods 
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that reflect a higher degree of accuracy is imperative. The current study uses IRT 
methods in a relatively novel way to examine the structure of the HADS, a trend 
that will hopefully continue. Studies employing Rasch analysis in the examination 
of the latent factor structure of the HADS have emerged only in recent years (23, 
25, 56), hopefully prompting a trend that will see the proliferation of IRT methods 
in psychometric validation studies. Employing a statistical method superior to the 
methods used in the vast majority of prior studies, a comprehensive and in-depth 
look at the underlying structure of the HADS was undertaken. The results from 
the current study provide compelling evidence of the unidimensional structure of 
the HADS and strongly advocate the adoption of the general psychological 
distress model.  
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Table 2. Loevinger H-values at c=.30, .40, .50 
 
    H-Values 
  Item 
Mean Score 
 c=.30  c=.40  c=.50 
Item  Prompt  1  1 2  1 2 3 
1 I feel tense or wound up .22  .45  .51   .59   
2 I still enjoy things I used to enjoy .44  .33   .61   .61  
3 I get a sort of frightened feeling as if something awful is about to happen .28  .46  .53   .60   
4 I can laugh and see the funny side of things .66  .40   .58   .58  
5 Worrying thoughts go through my mind .31  .46  .54   .60   
6 I feel cheerful .54  .46  .51   .56   
7 I can sit at ease and feel relaxed .36  .39  .40     .51 
8 I feel as if I am slowed down .12  -  -  - 
9 I get a sort of frightened feeling like "butterflies" in the stomach .42  .38  .42     .51 
10 I have lost interest in my appearance .59  .39  .44   - 
11 I feel restless as if I have to be on the move .23  .32  -  - 
12 I look forward with enjoyment to things .55  .33   .59   .60  
13 I get sudden feelings of panic .37  .49  .56   .64   
14 I can enjoy a good book or radio or TV program .68  -  -  - 
 Overall scale   .41  .49 .60  .60 .60 .51 
